In October 2023, Sharp Services (part of UDG Healthcare) announced the acquisition of Berkshire Sterile Manufacturing (a US-based fill-finish CDMO) for clinical and commercial sterile injectable products
Press release, May 8, 2020
The ensuing lapse in FDA appropriations meant the agency could not accept any new drug submissions during this fallow period, while the rejection rate for ongoing submissions had already risen from historical rates in the third quarter of 2025
It has only been diagnosed in some families of Boxers, probably as a result of genetic abnormalities in carnitine production or absorption
Eli Lilly submitted a supplemental new drug application (sNDA) in November 2024 for tirzepatide as a treatment for obstructive sleep apnea
If deficiency is confirmed and there is an indication, the use of supplements or specific measures is prescribed individually by a professional